Table 3.
Backgrounds of smoking patients.
| Parameter | Intervention group (FINE program participants) (n = 12) | Control group (usual program participants) (n = 12) | P |
|---|---|---|---|
| Mean (SD) age | 63.8 (8.17) | 58.3 (21.73) | 0.426 |
| Male (%) | 83.3 | 50.0 | 0.193 |
| Antihypertensive drugs (yes: %) | 50.0 | 33.3 | 0.168 |
| Drugs for treating dyslipidemia | 75.0 | 8.3 | 0.002 |
| Drugs for diabetes | 33.3 | 8.3 | 0.029 |
| Inhaled drugs | 16.7 | 8.3 | 0.018 |
| Smoking status (%) | |||
| Traditional cigarettes | 91.7 | 75.0 | 0.122 |
| Heated-not-burn/electronic tobacco products | 0.0 | 25.0 | |
| Both | 8.3 | 0.0 | |
| Mean (SD) amount consumed per day | |||
| Traditional cigarettes | 14.8 (7.08) | 12.4 (5.90) | 0.423 |
| Heated-not-burn/electronic tobacco products | 15.0 (0.00) | 9.7 (8.51) | 0.642 |
| Mean (SD) duration of smoking in years | 36.3 (14.5) | 32.4 (22.3) | 0.630 |
| Stage of change (%) | |||
| Indifference | 0.0 | 0.0 | 0.504 |
| Precontemplation | 33.3 | 8.3 | |
| Contemplation | 25.0 | 33.3 | |
| Preparation | 33.3 | 50.0 | |
| Unknown | 8.3 | 8.3 |